depression from semaglutide Does Cause Depression? Mood Effects Explained Penn study focuses on semaglutide

It's important to note that menstrual outcomes were not primary endpoints in major GLP-1 clinical trials, and much of the current understanding comes from post-marketing surveillance and patient reports

Doses above 3 mg/day are not FDA approved

Retatrutide is not yet FDA or Health Canada approved, which means there is no insurance coverage and no patient assistance programs

Staying hydrated with water and electrolyte drinks supports smooth digestion and prevents constipation, which sometimes follows diarrhea cycles

Recent studies indicate that approximately 1 in 8 Americansover 15 million individualshave used Ozempic or similar GLP-1 medications

proper monitoring is recommended and alternate therapy is required if pancreatitis is confirmed